Cyclin-dependent kinase 5 in synaptic plasticity, learning and memory

Journal of Neurochemistry

Volumn 99, Issue 2, 2006, Pages 353-370

  Angelo, Marco ^a   Plattner, Florian ^a   Giese, K Peter ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Behaviour; Cyclin dependent kinase 5; Hippocampus; Long term potentiation; p25; Transgenic mouse

Indexed keywords

CYCLIN DEPENDENT KINASE 5; PROTEIN P25;

CELL FUNCTION; DATA ANALYSIS; ENZYME ACTIVATION; ENZYME MECHANISM; HIPPOCAMPUS; HUMAN; LEARNING; LONG TERM POTENTIATION; MEMORY; MOLECULAR DYNAMICS; NERVE CELL DIFFERENTIATION; NERVE CELL PLASTICITY; NEUROPHYSIOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW;

ANIMALS; CYCLIN-DEPENDENT KINASE 5; HIPPOCAMPUS; HUMANS; LEARNING; LONG-TERM POTENTIATION; MEMORY; MICE; MICE, TRANSGENIC; NERVE TISSUE PROTEINS; NEURONAL PLASTICITY; SIGNAL TRANSDUCTION; SYNAPTIC TRANSMISSION;

MUS MUSCULUS;

EID: 33749164973     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2006.04040.x     Document Type: Review

References (140)

1. Agarwal-Mawal A. and Paudel H. K. (2001) Neuronal Cdc2-like protein kinase (Cdk5/p25) is associated with protein phosphatase 1 and phosphorylates inhibitor-2. J. Biol. Chem. 276, 23 712-23 718.
2. Anagnostaras S. G., Gale G. D. and Fanselow M. S. (2001) Hippocampus and contextual fear conditioning: recent controversies and advances. Hippocampus 11, 8-17.
3. Angelo M., Plattner F., Irvine E. E. and Giese K. P. (2003) Improved reversal learning and altered fear conditioning in transgenic mice with regionally restricted p25 expression. Eur. J. Neurosci. 18, 423-431.
4. Barclay J. W., Aldea M., Craig T. J., Morgan A. and Burgoyne R. D. (2004) Regulation of the fusion pore conductance during exocytosis by cyclin-dependent kinase 5. J. Biol. Chem. 279, 41 495-41 503.
5. Beffert U., Weeber E. J., Morfini G., Ko J., Brady S. T., Tsai L. H., Sweatt J. D. and Herz J. (2004) Reelin and cyclin-dependent kinase 5-dependent signals cooperate in regulating neuronal migration and synaptic transmission. J. Neurosci. 24, 1897-1906.
6. Benavides D. R. and Bibb J. A. (2004) Role of Cdk5 in drug abuse and plasticity. Ann. N. Y. Acad. Sci. 1025, 335-344.
7. Bibb J. A., Snyder G. L., Nishi A. et al. (1999) Phosphorylation of DARPP-32 by Cdk5 modulates dopamine signalling in neurons. Nature 402, 669-671.
8. Bibb J. A., Nishi A., O'Callaghan J. P. et al. (2001) Phosphorylation of protein phosphatase inhibitor-1 by Cdk5. J. Biol. Chem. 276, 14 490-14 497.
9. Bliss T. V. and Collingridge G. L. (1993) A synaptic model of memory: long-term potentiation in the hippocampus. Nature 361, 31-39.
10. Chen P. C. and Chen J. C. (2005) Enhanced Cdk5 activity and p35 translocation in the ventral striatum of acute and chronic methamphetamine- treated rats. Neuropsychopharmacology 30, 538-549.
11. Chergui K., Svenningsson P. and Greengard P. (2004) Cyclin-dependent kinase 5 regulates dopaminergic and glutamatergic transmission in the striatum. Proc. Natl Acad. Sci. USA 101, 2191-2196.
12. Ching Y. P., Pang A. S., Lam W. H., Qi R. Z. and Wang J. H. (2002) Identification of a neuronal Cdk5 activator-binding protein as Cdk5 inhibitor. J. Biol. Chem. 277, 15 237-15 240.
13. Cicero S. and Herrup K. (2005) Cyclin-dependent kinase 5 is essential for neuronal cell cycle arrest and differentiation. J. Neurosci. 25, 9658-9668.
14. Cifuentes F., Licona I. I., De Leon L., Medina P., De-Miguel F. F. and Morales M. A. (2004) Contribution of different calcium channels to long-term potentiation in superior cervical ganglion of the rat. Neuroscience 129, 647-653.
15. Cruz J. C., Tseng H. C., Goldman J. A., Shih H. and Tsai L. H. (2003) Aberrant Cdk5 activation by p25 triggers pathological events leading to neurodegeneration and neurofibrillary tangles. Neuron 40, 471-483.
16. Cull-Candy S., Brickley S. and Farrant M. (2001) NMDA receptor subunits: diversity, development and disease. Curr. Opin. Neurobiol. 11, 327-335.
17. Daw M. I., Bortolotto Z. A., Saulle E., Zaman S., Collingridge G. L. and Isaac J. T. (2002) Phosphatidylinositol 3 kinase regulates synapse specificity of hippocampal long-term depression. Nat. Neurosci. 5, 835-836.
18. DeKosky S. T., Ikonomovic M. D., Styren S. D., Beckett L., Wisniewski S., Bennett D. A., Cochran E. J., Kordower J. H. and Mufson E. J. (2002) Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment. Ann. Neurol. 51, 145-155.
19. Dhavan R. and Tsai L. H. (2001) A decade of CDK5. Nat. Rev. Mol. Cell. Biol. 2, 749-759.
20. Dhavan R., Greer P. L., Morabito M. A., Orlando L. R. and Tsai L. H. (2002) The cyclin-dependent kinase 5 activators p35 and p39 interact with the alpha-subunit of Ca2+/calmodulin-dependent protein kinase II and alpha-actinin-1 in a calcium-dependent manner. J. Neurosci. 22, 7879-7891.
21. D'Hooge R. and De Deyn P. P. (2001) Applications of the Morris water maze in the study of learning and memory. Brain. Res. Brain. Res. Rev. 36, 60-90.
22. Dineley K. T., Weeber E. J., Atkins C., Adams J. P., Anderson A. E. and Sweatt J. D. (2001) Leitmotifs in the biochemistry of LTP induction: amplification, integration and coordination. J. Neurochem. 77, 961-971.
23. Dudai Y. (2004) The neurobiology of consolidations, or, how stable is the engram? Annu. Rev. Psychol. 55, 51-86.
24. El-Husseini A. E., Schnell E., Chetkovich D. M., Nicoll R. A. and Bredt D. S. (2000) PSD-95 involvement in maturation of excitatory synapses. Science 290, 1364-1368.
25. Everitt B. J. and Robbins T. W. (1997) Central cholinergic systems and cognition. Annu. Rev. Psychol. 48, 649-684.
26. Feng J., Yan Z., Ferreira A., Tomizawa K., Liauw J. A., Zhuo M., Allen P. B., Ouimet C. C. and Greengard P. (2000) Spinophilin regulates the formation and function of dendritic spines. Proc. Natl Acad. Sci. USA 97, 9287-9292.
27. Fischer A., Sananbenesi F., Schrick C., Spiess J. and Radulovic J. (2002) Cyclin-dependent kinase 5 is required for associative learning. J. Neurosci. 22, 3700-3707.
28. Fischer A., Sananbenesi F., Schrick C., Spiess J. and Radulovic J. (2003) Regulation of contextual fear conditioning by baseline and inducible septo-hippocampal cyclin-dependent kinase 5. Neuropharmacology 44, 1089-1099.
29. Fischer A., Sananbenesi F., Pang P. T., Lu B. and Tsai L. H. (2005) Opposing roles of transient and prolonged expression of p25 in synaptic plasticity and hippocampus-dependent memory. Neuron 48, 825-838.
30. Flavell S. W., Cowan C. W., Kim T. K. et al. (2006) Activity-dependent regulation of MEF2 transcription factors suppresses excitatory synapse number. Science 311, 1008-1012.
31. Fletcher A. I., Shuang R., Giovannucci D. R., Zhang L., Bittner M. A. and Stuenkel E. L. (1999) Regulation of exocytosis by cyclin-dependent kinase 5 via phosphorylation of Munc18. J. Biol. Chem. 274, 4027-4035.
32. Floyd S. R., Porro E. B., Slepnev V. I., Ochoa G. C., Tsai L. H. and De Camilli P. (2001) Amphiphysin 1 binds the cyclin-dependent kinase (cdk) 5 regulatory subunit p35 and is phosphorylated by cdk5 and cdc2. J. Biol. Chem. 276, 8104-8110.
33. Fu A. K., Fu W. Y., Ng A. K., Chien W. W., Ng Y. P., Wang J. H. and Ip N. Y. (2004) Cyclin-dependent kinase 5 phosphorylates signal transducer and activator of transcription 3 and regulates its transcriptional activity. Proc. Natl Acad. Sci. USA 101, 6728-6733.
34. Fu A. K., Ip F. C., Fu W. Y., Cheung J., Wang J. H., Yung W. H. and Ip N. Y. (2005) Aberrant motor axon projection, acetylcholine receptor clustering, and neurotransmission in cyclin-dependent kinase 5 null mice. Proc. Natl Acad. Sci. USA 102, 15 224-15 229.
35. Futter M., Uematsu K., Bullock S. A., Kim Y., Hemmings H. C. Jr, Nishi A., Greengard P. and Nairn A. C. (2005) Phosphorylation of spinophilin by ERK and cyclin-dependent PK 5 (Cdk5). Proc. Natl Acad. Sci. USA 102, 3489-3494.
36. Gao C., Negash S., Guo H. T., Ledee D., Wang H. S. and Zelenka P. (2002) CDK5 regulates cell adhesion and migration in corneal epithelial cells. Mol. Cancer Res. 1, 12-24.
37. Giese K. P., Ris L. and Plattner F. (2005) Is there a role of the cyclin-dependent kinase 5 activator p25 in Alzheimer's disease? Neuroreport 16, 1725-1730.
38. Gomes A. R., Correia S. S., Carvalho A. L. and Duarte C. B. (2003) Regulation of AMPA receptor activity, synaptic targeting and recycling: role in synaptic plasticity. Neurochem. Res. 28, 1459-1473.
39. Gong X., Tang X., Wiedmann M., Wang X., Peng J., Zheng D., Blair L. A., Marshall J. and Mao Z. (2003) Cdk5-mediated inhibition of the protective effects of transcription factor MEF2 in neurotoxicity-induced apoptosis. Neuron 38, 33-46.
40. Good M., Day M. and Muir J. L. (1999) Cyclical changes in endogenous levels of oestrogen modulate the induction of LTD and LTP in the hippocampal CA1 region. Eur. J. Neurosci. 11, 4476-4480.
41. Gupta R. R., Sen S., Diepenhorst L. L., Rudick C. N. and Maren S. (2001) Estrogen modulates sexually dimorphic contextual fear conditioning and hippocampal long term potentiation (LTP) in rats. Brain Res. 888, 356-365.
42. Hahn C. M., Kleinholz H., Koester M. P., Grieser S., Thelen K. and Pollerberg G. E. (2005) Role of cyclin-dependent kinase 5 and its activator p35 in local axon and growth cone stabilization. Neuroscience 134, 449-465.
43. Holroyd P., Lang T., Wenzel D., De Camilli P. and Jahn R. (2002) Imaging direct, dynamin-dependent recapture of fusing secretory granules on plasma membrane lawns from PC12 cells. Proc. Natl Acad. Sci. USA 99, 16 806-16 811.
44. Huang K. X. and Paudel H. K. (2000) Ser67-phosphorylated inhibitor 1 is a potent protein phosphatase 1 inhibitor. Proc. Natl Acad. Sci. USA 97, 5824-5829.
45. Huntley G.W., Gil O. and Bozdagi O. (2002) The cadherin family of cell adhesion molecules: multiple roles in synaptic plasticity. Neuroscientist 8, 221-233.
46. Jeon D., Yang Y. M., Jeong M. J., Philipson K. D., Rhim H. and Shin H. S. (2003) Enhanced learning and memory in mice lacking Na+/Ca2+ exchanger 2. Neuron 38, 965-976.
47. Johansson J. U., Lilja L., Chen X. L. et al. (2005) Cyclin-dependent kinase 5 activators p35 and p39 facilitate formation of functional synapses. Brain. Res. Mol. Brain. Res. 138, 215-227.
48. Kansy J. W., Daubner S. C., Nishi A. et al. (2004) Identification of tyrosine hydroxylase as a physiological substrate for Cdk5. J. Neurochem. 91, 374-384.
49. Kato G. and Maeda S. (1999) Neuron-specific Cdk5 kinase is responsible for mitosis-independent phosphorylation of c-Src at Ser75 in human Y79 retinoblastoma cells. J. Biochem. (Tokyo) 126, 957-961.
50. Kawauchi T., Chihama K., Nishimura Y. V., Nabeshima Y. and Hoshino M. (2005) MAP1B phosphorylation is differentially regulated by Cdk5/p35, Cdk5/p25, and JNK. Biochem. Biophys. Res. Commun. 331, 50-55.
51. Kelleher R. J. 3rd, Govindarajan A., Jung H. Y., Kang H. and Tonegawa S. (2004) Translational control by MAPK signaling in long-term synaptic plasticity and memory. Cell 116, 467-479.
52. Kerokoski P., Suuronen T., Salminen A., Soininen H. and Pirttila T. (2004) Both N-methyl-D-aspartate (NMDA) and non-NMDA receptors mediate glutamate-induced cleavage of the cyclin-dependent kinase 5 (cdk5) activator p35 in cultured rat hippocampal neurons. Neurosci. Lett. 368, 181-185.
53. Kesavapany S., Lau K. F., McLoughlin D. M., Brownlees J., Ackerley S., Leigh P. N., Shaw C. E. and Miller C. C. (2001) p35/cdk5 binds and phosphorylates beta-catenin and regulates beta-catenin/presenilin-1 interaction. Eur. J. Neurosci. 13, 241-247.
54. Kesavapany S., Amin N., Zheng Y. L. et al. (2004) p35/cyclin-dependent kinase 5 phosphorylation of Ras guanine nucleotide releasing factor 2 (RasGRF2) mediates Rac-dependent extracellular signal-regulated kinase 1/2 activity, altering RasGRF2 and microtubule-associated protein 1b distribution in neurons. J. Neurosci. 24, 4421-4431.
55. Ko J., Humbert S., Bronson R. T., Takahashi S., Kulkarni A. B., Li E. and Tsai L. H. (2001) p35 and p39 are essential for cyclin-dependent kinase 5 function during neurodevelopment. J. Neurosci. 21, 6758-6771.
56. Krupa B. and Liu G. (2004) Does the fusion pore contribute to synaptic plasticity? Trends Neurosci. 27, 62-66.
57. Kwon Y. T., Tsai L. H. and Crandall J. E. (1999) Callosal axon guidance defects in p35(-/-) mice. J. Comp. Neurol. 415, 218-229.
58. Kwon Y. T., Gupta A., Zhou Y., Nikolic M. and Tsai L. H. (2000) Regulation of N-cadherin-mediated adhesion by the p35/Cdk5 kinase. Curr. Biol. 10, 363-372.
59. Lau K. F., Howlett D. R., Kesavapany S., Standen C. L., Dingwall C., McLoughlin D. M. and Miller C. C. (2002) Cyclin-dependent kinase-5/p35 phosphorylates presenilin 1 to regulate carboxy-terminal fragment stability. Mol. Cell. Neurosci. 20, 13-20.
60. Lazaro J. B., Kitzmann M., Poul M. A., Vandromme M., Lamb N. J. and Fernandez A. (1997) Cyclin dependent kinase 5, cdk5, is a positive regulator of myogenesis in mouse C2 cells. J. Cell. Sci. 110, 1251-1260.
61. Ledda F., Paratcha G. and Ibanez C. F. (2002) Target-derived GFRa1 as an attractive guidance signal for developing sensory and sympathetic axons via activation of Cdk5. Neuron 36, 387-401.
62. Lee S. Y., Wenk M. R., Kim Y., Nairn A. C. and De Camilli P. (2004) Regulation of synaptojanin 1 by cyclin-dependent kinase 5 at synapses. Proc. Natl Acad. Sci. USA 101, 546-551.
63. Lee S. Y., Voronov S., Letinic K., Nairn A. C., Di Paolo G. and De Camilli P. (2005) Regulation of the interaction between PIPKI gamma and talin by proline-directed protein kinases. J. Cell. Biol. 168, 789-799.
64. Leenders A. G. and Sheng Z. H. (2005) Modulation of neurotransmitter release by the second messenger-activated protein kinases: implications for presynaptic plasticity. Pharmacol. Ther. 105, 69-84.
65. Li B. S., Sun M. K., Zhang L., Takahashi S., Ma W., Vinade L., Kulkarni A. B., Brady R. O. and Pant H. C. (2001) Regulation of NMDA receptors by cyclin-dependent kinase-5. Proc. Natl Acad. Sci. USA 98, 12 742-12 747.
66. Li B. S., Zhang L., Takahashi S., Ma W., Jaffe H., Kulkarni A. B. and Pant H. C. (2002) Cyclin-dependent kinase 5 prevents neuronal apoptosis by negative regulation of c-Jun N-terminal kinase 3. EMBO J. 21, 324-333.
67. Li B. S., Ma W., Jaffe H., Zheng Y., Takahashi S., Zhang L., Kulkarni A. B. and Pant H. C. (2003) Cyclin-dependent kinase-5 is involved in neuregulin-dependent activation of phosphatidylinositol 3-kinase and Akt activity mediating neuronal survival. J. Biol. Chem. 278, 35 702-35 709.
68. Li C., Sasaki Y., Takei K et al. (2004) Correlation between semaphorin3A-induced facilitation of axonal transport and local activation of a translation initiation factor eukaryotic translation initiation factor 4E. J. Neurosci. 24, 6161-6170.
69. Li J., Grynspan F., Berman S., Nixon R. and Bursztajn S. (1996) Regional differences in gene expression for calcium activated neutral proteases (calpains) and their endogenous inhibitor calpastatin in mouse brain and spinal cord. J. Neurobiol. 30, 177-191.
70. Li Z., David G., Hung K. W., DePinho R. A., Fu A. K. and Ip N. Y. (2004) Cdk5/p35 phosphorylates mSds3 and regulates mSds3-mediated repression of transcription. J. Biol. Chem. 279, 54 438-54 444.
71. Lilien J. and Balsamo J. (2005) The regulation of cadherin-mediated adhesion by tyrosine phosphorylation/dephosphorylation of beta-catenin. Curr. Opin. Cell Biol. 17, 459-465.
72. Lilja L., Yang S. N., Webb D. L., Juntti-Berggren L., Berggren P. O. and Bark C. (2001) Cyclin-dependent kinase 5 promotes insulin exocytosis. J. Biol. Chem. 276, 34 199-34 205.
73. Lilja L., Johansson J. U., Gromada J., Mandic S. A., Fried G., Berggren P. O. and Bark C. (2004) Cyclin-dependent kinase 5 associated with p39 promotes Munc18-1 phosphorylation and Ca (2+)-dependent exocytosis. J. Biol. Chem. 279, 29 534-29 541.
74. Lim H. Y., Seow K. T., Li Q., Kesuma D., Wang J. H. and Qi R. Z. (2001) Structural insights into Cdk5 activation by a neuronal Cdk5 activator. Biochem. Biophys. Res. Commun. 285, 77-83.
75. Lin C. H., Yeh S. H., Lin C. H., Lu K. T., Leu T. H., Chang W. C. and Gean P. W. (2001) A role for the PI-3 kinase signaling pathway in fear conditioning and synaptic plasticity in the amygdala. Neuron 31, 841-851.
76. Lin W., Dominguez B., Yang J., Aryal P., Brandon E. P., Gage F. H. and Lee K. F. (2005) Neurotransmitter acetylcholine negatively regulates neuromuscular synapse formation by a Cdk5-dependent mechanism. Neuron 46, 569-579.
77. Liu F., Ma X. H., Ule J., Bibb J. A., Nishi A., DeMaggio A. J., Yan Z., Nairn A. C. and Greengard P. (2001) Regulation of cyclin-dependent kinase 5 and casein kinase 1 by metabotropic glutamate receptors. Proc. Natl Acad. Sci. USA 98, 11 062-11 068.
78. Liu F., Virshup D. M., Nairn A. C. and Greengard P. (2002) Mechanism of regulation of casein kinase I activity by group I metabotropic glutamate receptors. J. Biol. Chem. 277, 45 393-45 399.
79. Liu F., Su Y., Li B., Zhou Y., Ryder J., Gonzalez-DeWhitt P., May P. C. and Ni B. (2003) Regulation of amyloid precursor protein (APP) phosphorylation and processing by p35/Cdk5 and p25/Cdk5. FEBS Lett. 547, 193-196.
80. Liu J. and Kipreos E. T. (2000) Evolution of cyclin-dependent kinases (CDKs) and CDK-activating kinases (CAKs): differential conservation of CAKs in yeast and metazoa. Mol. Biol. Evol. 17, 1061-1074.
81. Malenka R. C. and Bear M. F. (2004) LTP and LTD: an embarrassment of riches. Neuron 44, 5-21.
82. Martin S. J. and Morris R. G. (2002) New life in an old idea: the synaptic plasticity and memory hypothesis revisited. Hippocampus 12, 609-636.
83. Matsubara M., Kusubata M., Ishiguro K., Uchida T., Titani K. and Taniguchi H. (1996) Site-specific phosphorylation of synapsin I by mitogen-activated protein kinase and Cdk5 and its effects on physiological functions. J. Biol. Chem. 271, 21 108-21 113.
84. Migaud M., Charlesworth P., Dempster M. et al. (1998) Enhanced longterm potentiation and impaired learning in mice with mutant postsynaptic density-95 protein. Nature 396, 433-439.
85. Moorthamer M. and Chaudhuri B. (1999) Identification of ribosomal protein L34 as a novel Cdk5 inhibitor. Biochem. Biophys. Res. Commun. 255, 631-638.
86. Morabito M. A., Sheng M. and Tsai L. H. (2004) Cyclin-dependent kinase 5 phosphorylates the N-terminal domain of the postsynaptic density protein PSD-95 in neurons. J. Neurosci. 24, 865-876.
87. Moran C. M., Donnelly M., Ortiz D., Pant H. C., Mandelkow E. M. and Shea T. B. (2005) Cdk5 inhibits anterograde axonal transport of neurofilaments but not that of tau by inhibition of mitogen-activated protein kinase activity. Brain. Res. Mol. Brain. Res. 134, 338-344.
88. Morfini G., Szebenyi G., Brown H., Pant H. C., Pigino G., DeBoer S., Beffert U. and Brady S. T. (2004) A novel CDK5-dependent pathway for regulating GSK3 activity and kinesin-driven motility in neurons. EMBO J. 23, 2235-2245.
89. Moy L. Y. and Tsai L. H. (2004) Cyclin-dependent kinase 5 phosphorylates serine 31 of tyrosine hydroxylase and regulates its stability. J. Biol. Chem. 279, 54 487-54 493.
90. Munton R. P., Vizi S. and Mansuy I. M. (2004) The role of protein phosphatase-1 in the modulation of synaptic and structural plasticity. FEBS Lett. 567, 121-128.
91. Murase S., Mosser E. and Schuman E. M. (2002) Depolarization drives beta-catenin into neuronal spines promoting changes in synaptic structure and function. Neuron 35, 91-105.
92. Nakano N., Nakao A., Ishidoh K., Tsuboi R., Kominami E., Okumura K. and Ogawa H. (2005) CDK5 regulates cell-cell and cell-matrix adhesion in human keratinocytes. Br. J. Dermatol. 153, 37-45.
93. Narita M., Shibasaki M., Nagumo Y., Narita M., Yajima Y. and Suzuki T. (2005) Implication of cyclin-dependent kinase 5 in the development of psychological dependence on and behavioral sensitization to morphine. J. Neurochem. 93, 1463-1468.
94. Negash S., Wang H. S., Gao C., Ledee D. and Zelenka P. (2002) Cdk5 regulates cell-matrix and cell-cell adhesion in lens epithelial cells. J. Cell. Sci. 115, 2109-2117.
95. Nguyen C. and Bibb J. A. (2003) Cdk5 and the mystery of synaptic vesicle endocytosis. J. Cell. Biol. 163, 697-699.
96. Nguyen P. V. and Woo N. H. (2003) Regulation of hippocampal synaptic plasticity by cyclic AMP-dependent protein kinases. Prog. Neurobiol. 71, 401-437.
97. Nikonenko I., Jourdain P., Alberi S., Toni N. and Muller D. (2002) Activity-induced changes of spine morphology. Hippocampus 12, 585-591.
98. Nishi A., Bibb J. A., Snyder G. L., Higashi H., Nairn A. C. and Greengard P. (2000) Amplification of dopaminergic signaling by a positive feedback loop. Proc. Natl Acad. Sci. USA 97, 12 840-12 845.
99. Norrholm S. D., Bibb J. A., Nestler E. J., Ouimet C. C., Taylor J. R. and Greengard P. (2003) Cocaine-induced proliferation of dendritic spines in nucleus accumbens is dependent on the activity of cyclin-dependent kinase-5. Neuroscience 116, 19-22.
100. O'Hare M. J., Kushwaha N., Zhang Y., Aleyasin H., Callaghan S. M., Slack R. S., Albert P. R., Vincent I. and Park D. S. (2005) Differential roles of nuclear and cytoplasmic cyclin-dependent kinase 5 in apoptotic and excitotoxic neuronal death. J. Neurosci. 25, 8954-8966.
101. Ohshima T., Ward J. M., Huh C. G., Longenecker G., Veeranna Pant H. C., Brady R. O., Martin L. J. and Kulkarni A. B. (1996) Targeted disruption of the cyclin-dependent kinase 5 gene results in abnormal corticogenesis, neuronal pathology and perinatal death. Proc. Natl Acad. Sci. USA 93, 11 173-11 178.
102. Ohshima T., Ogura H., Tomizawa K. et al. (2005) Impairment of hippocampal long-term depression and defective spatial learning and memory in p35 mice. J. Neurochem. 94, 917-925.
103. Patel L. S., Wenzel H. J. and Schwartzkroin P. A. (2004) Physiological and morphological characterization of dentate granule cells in the p35 knock-out mouse hippocampus: evidence for an epileptic circuit. J. Neurosci. 24, 9005-9014.
104. Patrick G. N., Zukerberg L., Nikolic M., de la Monte S., Dikkes P. and Tsai L. H. (1999) Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration. Nature 402, 615-622.
105. Plattner F., Angelo M. and Giese K. P. (2006) The roles of Cdk5 and GSK3 in tau phosphorylation. J. Biol. Chem. DOI:10.1074/jbc.M603469200.
106. Ris L., Angelo M., Plattner F., Capron B., Errington M. L., Bliss T. V., Godaux E. and Giese K. P. (2005) Sexual dimorphisms in the effect of low-level p25 expression on synaptic plasticity and memory. Eur. J. Neurosci. 21, 3023-3033.
107. Rosales J. L., Nodwell M. J., Johnston R. N. and Lee K. Y. (2000) Cdk5/ p25 (nck5a) interaction with synaptic proteins in bovine brain. J. Cell. Biochem. 78, 151-159.
108. Rosales J. L., Ernst J. D., Hallows J. and Lee K. Y. (2004) GTP-dependent secretion from neutrophils is regulated by Cdk5. J. Biol. Chem. 279, 53 932-53 936.
109. Roselli F., Tirard M., Lu J., Hutzler P., Lamberti P., Livrea P., Morabito M. and Almeida O. F. (2005) Soluble beta-amyloid1-40 induces NMDA-dependent degradation of postsynaptic density-95 at glutamatergic synapses. J. Neurosci. 25, 11 061-11 070.
110. Saito T., Onuki R., Fujita Y., Kusakawa G., Ishiguro K., Bibb J. A., Kishimoto T. and Hisanaga S. (2003) Developmental regulation of the proteolysis of the p35 cyclin-dependent kinase 5 activator by phosphorylation. J. Neurosci. 23, 1189-1197.
111. Sarker K. P. and Lee K. Y. (2004) L6 myoblast differentiation is modulated by Cdk5 via the PI3K-AKT-p70S6K signaling pathway. Oncogene 23, 6064-6070.
112. Saura C. A., Choi S. Y., Beglopoulos V. et al. (2004) Loss of presenilin function causes impairments of memory and synaptic plasticity followed by age-dependent neurodegeneration. Neuron 42, 23-36.
113. Schuman E. M. and Murase S. (2003) Cadherins and synaptic plasticity: activity-dependent cyclin-dependent kinase 5 regulation of synaptic beta-catenin-cadherin interactions. Philos. Trans. R. Soc. Lond. B: Biol. Sci. 358, 749-756.
114. Segal M. (2005) Dendritic spines and long-term plasticity. Nat. Rev. Neurosci. 6, 277-284.
115. Sharma P., Veeranna Sharma M., Amin N. D., Sihag R. K., Grant P., Ahn N., Kulkarni A. B. and Pant H. C. (2002) Phosphorylation of MEK1 by cdk5/p35 down-regulates the mitogen-activated protein kinase pathway. J. Biol. Chem. 277, 528-534.
116. Shelton S. B. and Johnson G. V. (2004) Cyclin-dependent kinase-5 in neurodegeneration. J. Neurochem. 88, 1313-1326.
117. Shuang R., Zhang L., Fletcher A., Groblewski G. E., Pevsner J. and Stuenkel E. L. (1998) Regulation of Munc-18/syntaxin 1A interaction by cyclin-dependent kinase 5 in nerve endings. J. Biol. Chem. 273, 4957-4966.
118. Smith D. (2003) Cdk5 in neuroskeletal dynamics. Neurosignals 12, 239-251.
119. Smith P. D., Mount M. P., Shree R. et al. (2006) Calpain-regulated p35/cdk5 plays a central role in dopaminergic neuron death through modulation of the transcription factor myocyte enhancer factor 2. J. Neurosci. 26, 440-447.
120. Sweatt J. D. (2004) Mitogen-activated protein kinases in synaptic plasticity and memory. Curr. Opin. Neurobiol. 14, 311-317.
121. Takahashi S., Ohshima T., Cho A. et al. (2005) Increased activity of cyclin-dependent kinase 5 leads to attenuation of cocaine-mediated dopamine signaling. Proc. Natl Acad. Sci. USA 102, 1737-1742.
122. Takei K., Yoshida Y. and Yamada H. (2005) Regulatory mechanisms of dynamin-dependent endocytosis. J. Biochem. (Tokyo) 137, 243-247.
123. Tan T. C., Valova V. A., Malladi C. S. et al. (2003) Cdk5 is essential for synaptic vesicle endocytosis. Nat. Cell. Biol. 5, 701-710.
124. Tomizawa K., Ohta J., Matsushita M., Moriwaki A., Li S. T., Takei K. and Matsui H. (2002) Cdk5/p35 regulates neurotransmitter release through phosphorylation and downregulation of P/Q-type voltage-dependent calcium channel activity. J. Neurosci. 22, 2590-2597.
125. Tomizawa K., Sunada S., Lu Y. F. et al. (2003) Cophosphorylation of amphiphysin I and dynamin I by Cdk5 regulates clathrin-mediated endocytosis of synaptic vesicles. J. Cell. Biol. 163, 813-824.
126. Vanderschuren L. J. and Kalivas P. W. (2000) Alterations in dopaminergic and glutamatergic transmission in the induction and expression of behavioral sensitization: a critical review of preclinical studies. Psychopharmacology (Berl.) 151, 99-120.
127. Vautrin J. and Barker J. L. (2003) Presynaptic quantal plasticity: Katz's original hypothesis revisited. Synapse 47, 184-199.
128. Venturin M., Moncini S., Villa V., Russo S., Bonati M. T., Larizza L. and Riva P. (2006) Mutations and novel polymorphisms in coding regions and UTRs of CDK5R1 and OMG genes in patients with nonsyndromic mental retardation. Neurogenetics 7, 59-66.
129. Wang J., Liu S., Fu Y., Wang J. H. and Lu Y. (2003) Cdk5 activation induces hippocampal CA1 cell death by directly phosphorylating NMDA receptors. Nat. Neurosci. 6, 1039-1047.
130. Wang Q., Walsh D. M., Rowan M. J., Selkoe D. J. and Anwyl R. (2004) Block of long-term potentiation by naturally secreted and synthetic amyloid beta-peptide in hippocampal slices is mediated via activation of the kinases c-Jun N-terminal kinase, cyclin-dependent kinase 5, and p38 mitogen-activated protein kinase as well as metabotropic glutamate receptor type 5. J. Neurosci. 24, 3370-3378.
131. Wei F. Y., Nagashima K., Ohshima T. et al. (2005a) Cdk5-dependent regulation of glucose-stimulated insulin secretion. Nat. Med. 11, 1104-1108.
132. Wei F. Y., Tomizawa K., Ohshima T. et al. (2005b) Control of cyclin-dependent kinase 5 (Cdk5) activity by glutamatergic regulation of p35 stability. J. Neurochem. 93, 502-512.
133. Wenzel H. J., Robbins C. A., Tsai L. H. and Schwartzkroin P. A. (2001) Abnormal morphological and functional organization of the hippocampus in a p35 mutant model of cortical dysplasia associated with spontaneous seizures. J. Neurosci. 21, 983-998.
134. Xin X., Ferraro F., Back N., Eipper B. A. and Mains R. E. (2004) Cdk5 and Trio modulate endocrine cell exocytosis. J. Cell. Sci. 117, 4739-4748.
135. Yan Z., Chi P., Bibb J. A., Ryan T. A. and Greengard P. (2002) Roscovitine: a novel regulator of P/Q-type calcium channels and transmitter release in central neurons. J. Physiol. 540, 761-770.
136. Zhang J., Krishnamurthy P. K. and Johnson G. V. (2002) Cdk5 phosphorylates p53 and regulates its activity. J. Neurochem. 81, 307-313.
137. Zhen X., Goswami S., Abdali S. A., Gil M., Bakshi K. and Friedman E. (2004) Regulation of cyclin-dependent kinase 5 and calcium/calmodulin-dependent protein kinase II by phosphatidylinositol-linked dopamine receptor in rat brain Mol. Pharmacol. 66, 1500-1507.
138. Zheng M., Leung C. L. and Liem R. K. (1998) Region-specific expression of cyclin-dependent kinase 5 (cdk5) and its activators, p35 and p39, in the developing and adult rat central nervous system. J. Neurobiol. 35, 141-159.
139. Zhu Y. S., Saito T., Asada A., Maekawa S. and Hisanaga S. (2005) Activation of latent cyclin-dependent kinase 5 (Cdk5)-p35 complexes by membrane dissociation. J. Neurochem. 94, 1535-1545.
140. Zucker R. S. and Regehr W. G. (2002) Short-term synaptic plasticity. Annu. Rev. Physiol. 64, 355-405.